SCHEMBL18922345

SCHEMBL18922345

COCC[C@](C)(C[C@@H](Cc1ccc(-c2cccc(Cl)c2)cc1)NC(=O)c1c[nH]nn1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MME P08473 14/20 0.53
MMEL1 Q495T6 7/20 0.51
ACE P12821 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19788096 1.00 MME (0.53) MMEMMEL1ACE
SCHEMBL24350342 0.93 MME (0.55) MMEMMEL1ACE
SCHEMBL19687848 0.93 MME (0.53) MMEMMEL1ACE
SCHEMBL15472655 0.93 MME (0.53) MMEMMEL1ACE
SCHEMBL19788049 0.92 MME (0.54) MMEMMEL1ACE
SCHEMBL15467397 0.91 MME (0.63) MMEMMEL1ACE
SCHEMBL19687925 0.91 MME (0.63) MMEMMEL1ACE
SCHEMBL15472669 0.88 MME (0.53) MMEMMEL1ACE
SCHEMBL19788097 0.88 MME (0.53) MMEMMEL1ACE
SCHEMBL19688106 0.87 MME (0.51) MMEMMEL1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670186-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2017-06-06 US disclosed